ASHLEY EPPINGER: Open Payments
NPI 1467064030 · EAGAN, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 65 payments from 21 companies in 2025. Trend: 2023 $213 · 2024 $461 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $344 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $102 |
| Lilly USA, LLC | 4 | $78 |
| Novo Nordisk Inc | 4 | $77 |
| Edwards Lifesciences Corporation | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Dexcom, Inc. | 2 | $42 |
| Abbott Laboratories | 2 | $42 |
| Amgen Inc. | 2 | $42 |
Products named: NURTEC ODT, TRINTELLIX, AIRSUPRA, FARXIGA, Wegovy, MOUNJARO, SAPIEN 3 Ultra RESILIA, SHINGRIX.
Industry payments across MN — which companies pay providers there.
